Clinical trials
Phase 3 Leukemia, Myeloid, Acute trials in Lithuania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 4 |
| Celgene | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 1 |
| Novartis Pharmaceuticals | 1 |
| Syndax Pharmaceuticals | 1 |
| University of Ulm | 1 |
| Vastra Gotaland Region | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 11 |
| Disease | 1 |
| Leukemia | 1 |
| Neoplasms | 1 |
| Pathologic Complete Response | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.